Precision Business Insights has published a report on the global herpes marker testing market, estimating its value at USD 1.7 billion in 2024 and is expected to expand at a compound annual growth rate (CAGR) of 4.9% over the forecast period 2025-2031. The report explores the market growth and potential opportunities in the market industry. Additionally, it offers a detailed analysis of how these elements will affect market demand dynamics and market performance throughout the forecast period.

View the detailed report description here - https://www.precisionbusinessinsights.com/market-reports/herpes-marker-testing-market      

The market refers to the global industry involved in the development, production, and distribution of diagnostic tests used to detect the presence of herpes simplex virus (HSV) infections specifically HSV-1 and HSV-2—in human samples. These tests identify antibodies, antigens, or viral DNA/RNA to confirm active or past infections.

Growth in this market is driven by the increasing prevalence of herpes infections, advancements in molecular diagnostics, growing awareness of sexually transmitted infections (STIs), and the demand for accurate and rapid testing methods across hospitals, clinics, and diagnostic laboratories.

The global herpes marker testing market segmentation:
1) By Test Type: Nucleic Acid Amplification Test, Viral Culture Tests, Antibody-Antigen Based Tests
2) By Virus Type: HSV-1, HSV-2, HSV-1 & HSV-2
3) By Application: Clinical Diagnosis, Research Use
4) By End User: Hospitals, Research Laboratories, Diagnostic Centres, Others

Request sample report at https://www.precisionbusinessinsights.com/request-sample/?product_id=21426

Regional Overview:
The report also examines the current concerns and their Future Effects on the herpes marker testing market by the region. The market has been segmented into numerous primary regions and a detailed evaluation of primary countries.

• North America (U.S., Canada)
• Europe (Germany, U.K., France, Italy, Russia, Spain, Rest of Europe)
• Asia-Pacific (China, India, Japan, Australia, Southeast Asia, Rest of Asia Pacific)
• Latin America (Mexico, Brazil, Argentina, Columbia, Rest of Latin America)
• Middle East & Africa (GCC, Egypt, Nigeria, South Africa, Rest of Middle East and Africa)

The competitive landscape is dominated by major players like Abbott Laboratories (U.S.), Thermo Fisher Scientific, Inc. (U.S.), BioMérieux SA (France), DiaSorin (Italy), Hoffmann-La Roche Ltd. (Switzerland), Luminex Corporation (U.S.), Quidel Corporation (U.S.), Qiagen N.V. (Germany), Merck KGaA (Germany), Hologic Inc. (U.S.), Norgen Biotek Corp. (Canada), Teco Diagnostics (U.S.)

About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.

Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.

Contact:
Mr. Satya
Precision Business Insights | Toll Free: +1 866 598 1553
Email: sales@precisionbusinessinsights.com
Kemp House, 152 – 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747